You are here

Article info

Article menu

This article has a correction. Please see:

Protocol
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

Authors

  • Yuesong Pan Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Xia Meng Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Weiqi Chen Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Jing Jing Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Jinxi Lin Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Yong Jiang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • S Claiborne Johnston Dell Medical School, The University of Texas System, Austin, Texas, USA PubMed articlesGoogle scholar articles
  • Philip M Bath Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK PubMed articlesGoogle scholar articles
  • Qiang Dong Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • An-Ding Xu Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Hao Li Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China PubMed articlesGoogle scholar articles
  • Yongjun Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, ChinaAdvanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaResearch Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yongjun Wang; yongjunwang{at}ncrcnd.org.cn
View Full Text

Citation

Pan Y, Meng X, Chen W, et al
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Stroke and Vascular Neurology 2022;7:e001480. doi: 10.1136/svn-2021-001480

Publication history

  • Received December 30, 2021
  • Accepted March 2, 2022
  • First published April 7, 2022.
Online issue publication 
October 18, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.